Work

Mutation-Selective Tumor Remission with Ras-Targeted, Whole Yeast-Based Immunotherapy

Year: 2004

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.can-04-1487

Authors: Yingnian Lu, Donald Bellgrau, Lori D. Dwyer-Nield, Alvin M. Malkinson, Richard C. Duke, Timothy C. Rodell, Alex Franzusoff

Institutions: GlobeImmune (United States), University of Colorado Health, University of Colorado Cancer Center, University of Colorado Denver

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cancer Center, University of Colorado, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE, Lung Tumor Promotion by BHT, G4081937184, G4159066013, Chemoprevention of Early Pulmonary Lesions in Mice, G830195429

OpenAlex ID: W2124601689

FWCI: 1.563

Cites: 23

Cited by: 71

Related to: 10